Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 09:09:35 GMT 2025
by
admin
on
Wed Apr 02 09:09:35 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
FPW3780T3E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78281
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
||
|
FDA ORPHAN DRUG |
508615
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1686
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C152352
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY | |||
|
100000177755
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY | |||
|
1847394-95-9
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY | |||
|
10539
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY | |||
|
DB14778
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY | |||
|
FPW3780T3E
Created by
admin on Wed Apr 02 09:09:35 GMT 2025 , Edited by admin on Wed Apr 02 09:09:35 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_144 | 1_200 |
| 1_257 | 1_317 |
| 1_363 | 1_421 |
| 2_22 | 2_96 |
| 2_144 | 2_200 |
| 2_257 | 2_317 |
| 2_363 | 2_421 |
| 1_131 | 3_216 |
| 1_219 | 2_219 |
| 1_220 | 2_220 |
| 1_223 | 2_223 |
| 1_226 | 2_226 |
| 2_131 | 4_216 |
| 3_22 | 3_90 |
| 3_139 | 3_198 |
| 4_22 | 4_90 |
| 4_139 | 4_198 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_293 |
| N | 2_293 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
doi: 10.1172/JCI83731
IN-VIVO
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|